Literature DB >> 10027599

Human uterine lymphocytes.

A King1, T Burrows, S Verma, S Hiby, Y W Loke.   

Abstract

During the luteal phase and the early months of pregnancy, there is a dense mucosal infiltration of CD56+ natural killer (NK) cells. These uterine NK cells have a phenotype (CD56bright, CD16-, mCD3-) which distinguishes them from peripheral blood NK cells (CD56dim, CD16bright, mCD3-). The uterine NK cells are in close association with extravillous trophoblast (EVT) cells which infiltrate into the decidua and maternal spiral arteries. This subpopulation of trophoblast expresses two human leukocyte antigen (HLA) class I molecules, HLA-G and HLA-C. Circulating NK cells express receptors for HLA class I molecules. We have recently found evidence that similar receptors are present on decidual NK cells belonging to both the Killer Inhibitory Receptor (KIR) and CD94 families. The repertoire of NK receptors expressed varies between different women. The findings indicate that decidual NK cells do have receptors for trophoblast HLA class I molecules. Experiments are underway to determine the effects of this interaction on NK cell function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10027599     DOI: 10.1093/humupd/4.5.480

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  31 in total

Review 1.  Immunology of pregnancy. Implications for the mother.

Authors:  Jill A Poole; Henry N Claman
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

2.  Evaluation of KIR genes in recurrent miscarriage.

Authors:  Ozlem Goruroglu Ozturk; Gulhan Sahın; Esin Damla Zıyanoglu Karacor; Umran Kucukgoz
Journal:  J Assist Reprod Genet       Date:  2012-06-06       Impact factor: 3.412

3.  Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro.

Authors:  Aleah D Hazan; Samantha D Smith; Rebecca L Jones; Wendy Whittle; Stephen J Lye; Caroline E Dunk
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

4.  Human dNK cell function is differentially regulated by extrinsic cellular engagement and intrinsic activating receptors in first and second trimester pregnancy.

Authors:  Jianhong Zhang; Caroline E Dunk; Melissa Kwan; Rebecca L Jones; Lynda K Harris; Sarah Keating; Stephen J Lye
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

5.  Menstrual cycle hormones induce changes in functional interactions between lymphocytes and decidual vascular endothelial cells.

Authors:  Marianne J van den Heuvel; Julie Horrocks; Siamak Bashar; Suzanne Taylor; Suzanne Burke; Kota Hatta; Jennifer E Lewis; B Anne Croy
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

6.  Serious foetal growth restriction is associated with reduced proportions of natural killer cells in decidua basalis.

Authors:  Irina P Eide; Toril Rolfseng; Christina V Isaksen; Reidun Mecsei; Borghild Roald; Stian Lydersen; Kjell A Salvesen; Nina K Harsem; Rigmor Austgulen
Journal:  Virchows Arch       Date:  2005-11-19       Impact factor: 4.064

Review 7.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Authors:  Isabela Pedroza-Pacheco; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

Review 8.  The Role of Progesterone in Feto-Maternal Immunological Cross Talk.

Authors:  Julia Szekeres-Bartho
Journal:  Med Princ Pract       Date:  2018-06-27       Impact factor: 1.927

9.  Complete and unidirectional conversion of human embryonic stem cells to trophoblast by BMP4.

Authors:  Mitsuyoshi Amita; Katsuyuki Adachi; Andrei P Alexenko; Sunilima Sinha; Danny J Schust; Laura C Schulz; R Michael Roberts; Toshihiko Ezashi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

10.  Aberrant endometrial features of pregnancy in diabetic NOD mice.

Authors:  Suzanne D Burke; Hongmei Dong; Aleah D Hazan; B Anne Croy
Journal:  Diabetes       Date:  2007-09-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.